Indapta Therapeutics Inc

Indapta Therapeutics Inc. develops biotechnology solutions focused on cellular immunotherapies. The Company commercializes off-the-shelf therapies and conducts clinical trials for proprietary allogeneic G-NK cell therapy targeting cancer and autoimmune diseases. Indapta Therapeutics Inc serves patients in the United States.